 Leflunomide is contraindicated in pregnant women yet human data from leflunomide exposed pregnancies do not indicate an embryofetal toxicity signal . The objective of the present analysis was to report pregnancy outcomes for leflunomide exposed pregnancies in clinical trials and in the post marketing setting .

@highlight Leflunomide exposed pregnancy outcomes were consistent with the general population.
@highlight Birth defects were distributed evenly without a trend or pattern.
@highlight These findings do not indicate an embryofetal toxicity signal for leflunomide.
